In vivo LNP-CRISPR Approaches for the Treatment of Hemophilia Jeong Hyeon LeeJeong Pil Han Leading Article Open access 28 March 2024 Pages: 239 - 248
Unwinding Helicase MCM Functionality for Diagnosis and Therapeutics of Replication Abnormalities Associated with Cancer: A Review Arathi RadhakrishnanRitwik GangopadhyayRajpal Srivastav Review Article 26 March 2024 Pages: 249 - 264
Advances in Radioligand Theranostics in Oncology Ismaheel O. LawalSofiullah O. AbubakarMike M. Sathekge Review Article 31 March 2024 Pages: 265 - 289
Lutetium-177 Labelled Anti-PSMA Monoclonal Antibody (Lu-TLX591) Therapy for Metastatic Prostate Cancer: Treatment Toxicity and Outcomes Hanh NguyenKathryn HirdNat P. Lenzo Original Research Article Open access 06 March 2024 Pages: 291 - 299
Identification of Plasmatic MicroRNA-206 as New Predictor of Early Recurrence of Atrial Fibrillation After Catheter Ablation Using Next-generation Sequencing Filip ŠustrTáňa MacháčkováJan Novák Original Research Article Open access 08 March 2024 Pages: 301 - 310
Diagnostic Approaches to Investigate JAK2-Unmutated Erythrocytosis Based on a Single Tertiary Center Experience Youngeun LeeSoo Hyun SeoSang Mee Hwang Original Research Article Open access 03 April 2024 Pages: 311 - 318
Estimating the Prognostic Value of the NTRK Fusion Biomarker for Comparative Effectiveness Research in The Netherlands Irene SantiHeleen VellekoopMaureen Rutten-van Mölken Original Research Article Open access 14 April 2024 Pages: 319 - 328
Molecular Dynamic Simulations to Determine Individualized Therapy: Tetrabenazine for the GNAO1 Encephalopathy E246K Variant Raffaele FalsaperlaVincenzo SortinoSimone Ronsisvalle Original Research Article 06 April 2024 Pages: 329 - 337
Comment on “Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta‑Analysis” Jun MaWei Han Letter to the Editor 10 April 2024 Pages: 345 - 346